Cargando…

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

BACKGROUND: There is an urgent need for biomarkers for the early detection of ovarian cancer (OC). The purpose of this study was to assess whether changes in serum levels of lecithin-cholesterol acyltransferase (LCAT), sex hormone-binding globulin (SHBG), glucose-regulated protein, 78 kDa (GRP78), c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, Matthew R, Graham, Ciaren, D'Amato, Alfonsina, Gentry-Maharaj, Aleksandra, Ryan, Andy, Kalsi, Jatinderpal K, Ainley, Carol, Whetton, Anthony D, Menon, Usha, Jacobs, Ian, Graham, Robert L J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572165/ https://www.ncbi.nlm.nih.gov/pubmed/28664912 http://dx.doi.org/10.1038/bjc.2017.199

Ejemplares similares

Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel
por: Russell, Matthew R., et al.
Publicado: (2019)

Novel risk models for early detection and screening of ovarian cancer
por: Russell, Matthew R., et al.
Publicado: (2016)

Protein Z: A putative novel biomarker for early detection of ovarian cancer
por: Russell, Matthew R., et al.
Publicado: (2016)

Socioeconomic Status and Ovarian Cancer Stage at Diagnosis: A Study Nested Within UKCTOCS
por: Karpinskyj, Chloe, et al.
Publicado: (2020)

Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2014)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Bailey, Katharine, et al.
Publicado: (2015)

A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer
por: Vázquez, Manuel A., et al.
Publicado: (2018)

Improved early detection of ovarian cancer using longitudinal multimarker models
por: Whitwell, Harry J., et al.
Publicado: (2020)

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015)

Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2017)

Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer
por: Pedersen, J W, et al.
Publicado: (2013)

Panel of serum biomarkers (GastroPanel) in diagnosis of atrophic gastritis and Helicobacter pylori infection: a protocol of systematic review and meta-analysis
por: Wu, Dan, et al.
Publicado: (2022)

Generation of a mouse SWATH-MS spectral library to quantify 10148 proteins involved in cell reprogramming
por: Ulanga, Uxue, et al.
Publicado: (2021)

UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis
por: Burnell, Matthew, et al.
Publicado: (2021)

S-Vest: a novel hybrid method to allow standardised patients to put on the objective physical examination findings of a disease
por: Berg, Dale, et al.
Publicado: (2019)

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
por: Burford, B, et al.
Publicado: (2013)

Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study
por: Yang, Xin, et al.
Publicado: (2018)

Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations
por: Sen, Ethan S, et al.
Publicado: (2017)

Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Dilley, James, et al.
Publicado: (2020)

Personalised virtual gene panels reduce interpretation workload and maintain diagnostic rates of proband-only clinical exome sequencing for rare disorders
por: Molina-Ramírez, Leslie Patricia, et al.
Publicado: (2022)

Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
por: Ameri, K, et al.
Publicado: (2010)

Ovarian cancer screening—Current status, future directions()
por: Menon, Usha, et al.
Publicado: (2014)

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis
por: Walsh, N, et al.
Publicado: (2010)

FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer
por: Baker, M J, et al.
Publicado: (2008)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Diagnostic Stewardship of Respiratory Pathogen Panel Utilization
por: Kressel, Amy, et al.
Publicado: (2021)

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness
por: Molleví, D G, et al.
Publicado: (2008)

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
por: Green, A R, et al.
Publicado: (2013)

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
por: Shipitsin, M, et al.
Publicado: (2014)

Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset
por: Blyuss, Oleg, et al.
Publicado: (2015)

Osteopontin is a marker for cancer aggressiveness and patient survival
por: Weber, G F, et al.
Publicado: (2010)

The clinical diagnostic accuracy of rapid detection of healthcare-associated bloodstream infection in intensive care using multipathogen real-time PCR technology
por: Dark, Paul, et al.
Publicado: (2011)

Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar
por: Kalsi, Jatinderpal K., et al.
Publicado: (2021)

Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Kalsi, Jatinderpal, et al.
Publicado: (2021)

Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour)
por: Hong, H, et al.
Publicado: (2011)

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
por: Oikonomopoulou, K, et al.
Publicado: (2008)

FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer
por: Cimino, Y, et al.
Publicado: (2012)

Epstein-Barr virus as a marker of biological aggressiveness in breast cancer
por: Mazouni, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lb1okdu5uiapukhk7p9s71oabu